Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 16
2003 13
2004 22
2005 18
2006 18
2007 26
2008 10
2009 19
2010 14
2011 18
2012 18
2013 23
2014 26
2015 29
2016 21
2017 21
2018 19
2019 21
2020 29
2021 28
2022 26
2023 22
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

413 results

Results by year

Filters applied: . Clear all
Page 1
Masitinib Inhibits Hepatitis A Virus Replication.
Sasaki-Tanaka R, Shibata T, Moriyama M, Kogure H, Hirai-Yuki A, Okamoto H, Kanda T. Sasaki-Tanaka R, et al. Among authors: okamoto h. Int J Mol Sci. 2023 Jun 3;24(11):9708. doi: 10.3390/ijms24119708. Int J Mol Sci. 2023. PMID: 37298659 Free PMC article.
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Früh M, Qian W, Tamura T, Samantas E, Shibata T, Perrone F, Gallo C, Gridelli C, Martelli O, Lee SM. Rossi A, et al. Among authors: okamoto h. J Clin Oncol. 2012 May 10;30(14):1692-8. doi: 10.1200/JCO.2011.40.4905. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473169 Review.
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.
Kenmotsu H, Yamamoto N, Misumi T, Yoh K, Saito H, Sugawara S, Yamazaki K, Nakagawa K, Sugio K, Seto T, Toyooka S, Date H, Mitsudomi T, Okamoto I, Yokoi K, Saka H, Okamoto H, Takiguchi Y, Takahashi T, Tsuboi M. Kenmotsu H, et al. Among authors: okamoto h. J Clin Oncol. 2023 Dec 1;41(34):5242-5246. doi: 10.1200/JCO.23.00179. Epub 2023 Sep 1. J Clin Oncol. 2023. PMID: 37656928 Clinical Trial.
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.
Kenmotsu H, Yamamoto N, Yamanaka T, Yoshiya K, Takahashi T, Ueno T, Goto K, Daga H, Ikeda N, Sugio K, Seto T, Toyooka S, Date H, Mitsudomi T, Okamoto I, Yokoi K, Saka H, Okamoto H, Takiguchi Y, Tsuboi M. Kenmotsu H, et al. Among authors: okamoto h. J Clin Oncol. 2020 Jul 1;38(19):2187-2196. doi: 10.1200/JCO.19.02674. Epub 2020 May 14. J Clin Oncol. 2020. PMID: 32407216 Clinical Trial.
Anelloviridae taxonomy update 2023.
Varsani A, Kraberger S, Opriessnig T, Maggi F, Celer V, Okamoto H, Biagini P. Varsani A, et al. Among authors: okamoto h. Arch Virol. 2023 Oct 21;168(11):277. doi: 10.1007/s00705-023-05903-6. Arch Virol. 2023. PMID: 37864606
In Reply.
Takagi Y, Hosomi Y, Shibuya M, Okamoto H. Takagi Y, et al. Among authors: okamoto h. Oncologist. 2015 Jul;20(7):e22. doi: 10.1634/theoncologist.2015-0070. Epub 2015 Jun 11. Oncologist. 2015. PMID: 26069282 Free PMC article.
Genetic Variability and Evolution of Hepatitis E Virus.
Primadharsini PP, Nagashima S, Okamoto H. Primadharsini PP, et al. Among authors: okamoto h. Viruses. 2019 May 18;11(5):456. doi: 10.3390/v11050456. Viruses. 2019. PMID: 31109076 Free PMC article. Review.
ICTV Virus Taxonomy Profile: Hepeviridae 2022.
Purdy MA, Drexler JF, Meng XJ, Norder H, Okamoto H, Van der Poel WHM, Reuter G, de Souza WM, Ulrich RG, Smith DB. Purdy MA, et al. Among authors: okamoto h. J Gen Virol. 2022 Sep;103(9). doi: 10.1099/jgv.0.001778. J Gen Virol. 2022. PMID: 36170152
Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial.
Shimokawa T, Okamoto H, Machida R, Misumi Y, Hosomi Y, Yoneshima Y, Tanaka H, Okishio K, Simizu J, Goto K, Akamatsu H, Kubota K, Nakagawa K, Horinouchi H, Ando M, Kataoka T, Ohe Y. Shimokawa T, et al. Among authors: okamoto h. Lung Cancer. 2023 Jul;181:107195. doi: 10.1016/j.lungcan.2023.107195. Epub 2023 Apr 22. Lung Cancer. 2023. PMID: 37156212 Free article. Clinical Trial.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Satouchi M, Nosaki K, Takahashi T, Nakagawa K, Aoe K, Kurata T, Sekine A, Horiike A, Fukuhara T, Sugawara S, Umemura S, Saka H, Okamoto I, Yamamoto N, Sakai H, Kishi K, Katakami N, Horinouchi H, Hida T, Okamoto H, Atagi S, Ohira T, Rong Han S, Noguchi K, Ebiana V, Hotta K. Satouchi M, et al. Among authors: okamoto h. Cancer Sci. 2021 Dec;112(12):5000-5010. doi: 10.1111/cas.15144. Epub 2021 Nov 5. Cancer Sci. 2021. PMID: 34543477 Free PMC article. Clinical Trial.
413 results